Cargando…

Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction

The chiral structure of antibiotic vancomycin (Van) was exploited as an innovative coordination sphere for the preparation of an IrCp* based hybrid catalysts. We found that Van is able to coordinate iridium (Ir(III)) and the complexation was demonstrated by several analytical techniques such as MALD...

Descripción completa

Detalles Bibliográficos
Autores principales: Facchetti, Giorgio, Pellegrino, Sara, Bucci, Raffaella, Nava, Donatella, Gandolfi, Raffaella, Christodoulou, Michael S., Rimoldi, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695689/
https://www.ncbi.nlm.nih.gov/pubmed/31366120
http://dx.doi.org/10.3390/molecules24152771
_version_ 1783444094240948224
author Facchetti, Giorgio
Pellegrino, Sara
Bucci, Raffaella
Nava, Donatella
Gandolfi, Raffaella
Christodoulou, Michael S.
Rimoldi, Isabella
author_facet Facchetti, Giorgio
Pellegrino, Sara
Bucci, Raffaella
Nava, Donatella
Gandolfi, Raffaella
Christodoulou, Michael S.
Rimoldi, Isabella
author_sort Facchetti, Giorgio
collection PubMed
description The chiral structure of antibiotic vancomycin (Van) was exploited as an innovative coordination sphere for the preparation of an IrCp* based hybrid catalysts. We found that Van is able to coordinate iridium (Ir(III)) and the complexation was demonstrated by several analytical techniques such as MALDI-TOF, UV, Circular dichroism (CD), Raman IR, and NMR. The hybrid system so obtained was employed in the Asymmetric Transfer Hydrogenation (ATH) of cyclic imines allowing to obtain a valuable 61% e.e. (R) in the asymmetric reduction of quinaldine 2. The catalytic system exhibited a saturation kinetics with a calculated efficiency of K(cat)/K(M) = 0.688 h(−1)mM(−1).
format Online
Article
Text
id pubmed-6695689
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66956892019-09-05 Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction Facchetti, Giorgio Pellegrino, Sara Bucci, Raffaella Nava, Donatella Gandolfi, Raffaella Christodoulou, Michael S. Rimoldi, Isabella Molecules Communication The chiral structure of antibiotic vancomycin (Van) was exploited as an innovative coordination sphere for the preparation of an IrCp* based hybrid catalysts. We found that Van is able to coordinate iridium (Ir(III)) and the complexation was demonstrated by several analytical techniques such as MALDI-TOF, UV, Circular dichroism (CD), Raman IR, and NMR. The hybrid system so obtained was employed in the Asymmetric Transfer Hydrogenation (ATH) of cyclic imines allowing to obtain a valuable 61% e.e. (R) in the asymmetric reduction of quinaldine 2. The catalytic system exhibited a saturation kinetics with a calculated efficiency of K(cat)/K(M) = 0.688 h(−1)mM(−1). MDPI 2019-07-30 /pmc/articles/PMC6695689/ /pubmed/31366120 http://dx.doi.org/10.3390/molecules24152771 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Facchetti, Giorgio
Pellegrino, Sara
Bucci, Raffaella
Nava, Donatella
Gandolfi, Raffaella
Christodoulou, Michael S.
Rimoldi, Isabella
Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction
title Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction
title_full Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction
title_fullStr Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction
title_full_unstemmed Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction
title_short Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction
title_sort vancomycin-iridium (iii) interaction: an unexplored route for enantioselective imine reduction
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695689/
https://www.ncbi.nlm.nih.gov/pubmed/31366120
http://dx.doi.org/10.3390/molecules24152771
work_keys_str_mv AT facchettigiorgio vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction
AT pellegrinosara vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction
AT bucciraffaella vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction
AT navadonatella vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction
AT gandolfiraffaella vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction
AT christodouloumichaels vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction
AT rimoldiisabella vancomyciniridiumiiiinteractionanunexploredrouteforenantioselectiveiminereduction